vTv Therapeutics (VTVT) Misses Q2 EPS by 15c
vTv Therapeutics (NASDAQ: VTVT) reported Q2 EPS of ($1.05), $0.15 worse than the analyst estimate of ($0.90).
For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.
vTv Therapeutics (NASDAQ: VTVT) reported Q2 EPS of ($1.05), $0.15 worse than the analyst estimate of ($0.90).
For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.